Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
GE Healthcare (China) Co., Ltd. 1F-5F BLD 1, No.1 Tongji South Road, Beijing Economic-Technological Development Area Beijing China

GE Healthcare (China) Co., Ltd. 1F-5F BLD 1, No.1 Tongji South Road, Beijing Economic-Technological Development Area Beijing China Recalls

All product recalls associated with GE Healthcare (China) Co., Ltd. 1F-5F BLD 1, No.1 Tongji South Road, Beijing Economic-Technological Development Area Beijing China.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

442

Class I (Serious)

138

Most Recent

Dec 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 421–440 of 7663 recalls

SIGNA MR355/MR360 MRI System (GE Healthcare) – SAR monitoring (2025)

For certain MR systems, a scan can be resumed following a Power Monitor trip when the "6-minute average SAR" is above the limit indicated on the "SAR Display". The user interface may incorrectly enable a scan to proceed earlier than intended. If resumed by the operator, such a scan can result in potential excessive tissue heating, especially if the patient is in contact with a conductive material or has an implant.

Moderate

FDAJan 31, 2025Nationwide• GE Healthcare (China) Co., Ltd. 1F-5F BLD 1, No.1 Tongji South Road, Beijing Economic-Technological Development Area Beijing China

Beverage Base Lemonade (OCBW) – Undeclared Yellow #5 (2025)

Undeclared Allergen

Undeclared Yellow #5

Class IIModerate

FDAJan 31, 2025AR, CA, CO +5 more• OCBW INC

Beverage Base Sweet&Sour (OCBW) – Undeclared Yellow #5 (2025)

1...20 212223 24...384

Page 22 of 384Next

Undeclared Allergen

Undeclared Yellow #5

Class IIModerate

FDAJan 31, 2025AR, CA, CO +5 more• OCBW INC

Refillable Medicine Bottles (Cabinet Health) – Child-Resistance Failure (2025)

This recall involves certain Cabinet Health 4 oz. Refillable Medicine Bottles with ABS plastic lids. The bottles are made of clear glass with blue, turquoise, orange or purple plastic lids labeled \"CABINET.\" Cabinet Health sold the bottles filled with over-the-counter drugs or as empty 4 oz. bottles. The recalled empty 4 oz. bottles were sold via cabinethealth.com from March 2023 through July 2024. Consumers with recalled empty bottles can identify them by the date of purchase. The recalled bottles filled with over-the-counter drugs have the following date codes on a sticker on the bottom of the bottle. Medication Name Lid Color Date Codes Tension Headache - Refillable Glass Bottle (Acetaminophen 500mg Caffeine 65mg) - 100 Count Blue 2029J07223 2029J07623 2029J07723 Allergy Relief - Refillable Glass Bottle (Diphenhydramine HCl 25mg) - 120 Count Turquoise 2265J07323 Pain Reliever and Nighttime Sleep Aid - Refillable Glass Bottle (Acetaminophen 500mg, Diphenhydramine 25mg) - 120 Count Blue 2127J06823 2127J23323 3040J23323 3051J23323 3051J23423Pain Reliever and Fever Reducer - Refillable Glass Bottle (Acetaminophen 500mg) - 120 Count Blue 2286J06323 2286J06523 2286J06623 2287J06623 2287J06723 Cough Relief - Refillable Glass Bottle (Dextromethorphan Hbr 15mg) - 60 Count Orange 2010J06923 2010J07023 3004J29623 3010J29623 3025J29623 Sleep Aid - Refillable Glass Bottle (Diphenhydramine HCl 50mg) - 70 Count Purple 3021J06823 3021J06923 3034J23423 3034J23523

High

CPSCJan 30, 2025Nationwide• Cabinet Health Inc., of Washington, D.C.

Potassium Chloride Tablets (Harvard Drug) – Dissolution Failure (2025)

Failed Dissolution Specifications.

Class IIModerate

FDAJan 30, 2025Nationwide• The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Leica CM1950 Cryostat (Leica) – firmware data loss (2025)

Firm became aware of software issues related to most recent firmware update which could result in loss of patient tissue.

High

FDAJan 30, 2025Nationwide• LEICA BIOSYSTEMS NUSSLOCH GMBH Heidelberger Str. 17-19 Nussloch Germany

Dark Chocolate Pretzels (Woodstock Farms) – Undeclared Milk (2025)

Undeclared Allergen

Undeclared Allergen - Milk

Class IHigh

FDAJan 27, 2025NY• United Natural Trading Inc. dba Woodstock Farms

Starcraft Allstar Bus (Starcraft) – exit handle issue (2025)

Fire/Burn Risk

Forest River Bus, LLC (Forest River) is recalling certain 2023-2024 Starcraft Starlite and 2023 Allstar transit buses. The emergency exit handles and labels are not easily accessible which can prevent or delay the exit of passengers in the event of an emergency. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard (FMVSS) number 217, "Bus Emergency Exits and Window Retention and Release."

High

NHTSAJan 22, 2025Nationwide• STARCRAFT BUS

Lorazepam Tablets 1mg (Major) – Potency Concern (2025)

Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.

Class IIModerate

FDAJan 21, 2025Nationwide• The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Lorazepam Tablets 0.5mg (Major) – Potency Concern (2025)

Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.

Class IIModerate

FDAJan 21, 2025Nationwide• The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Lorazepam Tablets 2mg (Major) – Potency Concern (2025)

Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.

Class IIModerate

FDAJan 21, 2025Nationwide• The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

HPV Control Panel (Microbiologics) – quality control issue (2025)

Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 L1) was low enough to cause QC failures, no detection, or invalid results on some instruments and assays.

Moderate

FDAJan 20, 2025Nationwide• Microbiologics Inc

Mercedes-Benz E 450 (Mercedes-Benz) – tire manufacturing (2025)

Mercedes-Benz USA, LLC (MBUSA) is recalling certain 2018 E 400 Cabriolet, E 400 Coupe, 2019 E 450 Cabriolet, and E 450 Coupe vehicles. The tires were incorrectly marked with the wrong maximum inflation pressure and may not meet the strength requirements for the stated pressure. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard (FMVSS) number 139, "New Pneumatic Radial Tires for Light Vehicles."

High

NHTSAJan 17, 2025Nationwide• MERCEDES-BENZ

RayStation Planning System (RaySearch) – density uncertainty (2025)

Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.

Moderate

FDAJan 16, 2025Nationwide• RAYSEARCH LABORATORIES AB Eugeniavagen 18c Stockholm Sweden